SequelSEC

Hypha Labs, Inc. FUNI

Services-Testing Laboratories · CIK 0001502966 · Fiscal year ends 0930

AnnualQuarterlyTTM
Revenue
$2.73M
Fiscal year ended 2022-12-31
Operating income
-$927.90K
Fiscal year ended 2022-12-31
Free cash flow
-$8.30K
Fiscal year ended 2022-12-31

Valuation, from the filing

Public float$3.07MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-03-31
Float per share$0.02Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-03-31, not today.

Hypha Labs, Inc. (FUNI) reported revenue of $2.73M and net income of -$2.02M for the fiscal year ended 2022-12-31. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Hypha Labs, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Testing Laboratories.

Income

Hypha Labs, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2022-12-31
Revenue$2.73M
Cost of revenue$1.63M
Gross profit$1.09M
Operating income-$927.90K
Net income-$2.02M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrative$495.63K
Selling & marketingUnavailable

Balance

Hypha Labs, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2022-12-31
Cash & equivalentsUnavailable
Total assets$1.18M
Current assets$508.25K
Total liabilities$3.73M
Current liabilities$1.97M
Total equity incl. NCI-$2.88M
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivable$301.87K
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$571.12K

Cash flow

Hypha Labs, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2022-12-31
Operating cash flow$9.60K
Capital expenditures$17.91K
Investing cash flow-$154.56K
Financing cash flow$210.48K
Net change in cash$65.53K
Stock-based compensation$488.58K
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$181.44K

Derived

Hypha Labs, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2022-12-31
Free cash flow-$8.30K
Gross margin40.1%
Operating margin-34.0%
FCF margin-0.3%
SBC / revenue17.9%
Current ratio0.26x
Revenue YoY growth0.9%
Net margin-74.1%
R&D / revenueUnavailable
CapEx / revenue0.7%
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open FUNI in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-15View SEC filing
10-Q · Filed 2026-02-17View SEC filing
10-K · Filed 2026-01-15View SEC filing
10-Q · Filed 2025-08-21View SEC filing
10-Q · Filed 2025-06-13View SEC filing

Companies in the same industry

AIDX NEO ULS

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.